Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective

Chronic kidney disease (CKD) is a major public health concern in the Middle East and Africa (MEA) region and a leading cause of death in patients with type 2 diabetes mellitus (T2DM) and hypertension. Early initiation of sodium-glucose cotransporter - 2 inhibitors (SGLT-2i) and proper sequencing wit...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of nephrology and renovascular disease 2024-01, Vol.17, p.1-16
Main Authors:	Elkeraie, Ahmed Fathi, Al-Ghamdi, Saeed, Abu-Alfa, Ali K, Alotaibi, Torki, AlSaedi, Ali Jasim, AlSuwaida, Abdulkareem, Arici, Mustafa, Ecder, Tevfik, Ghnaimat, Mohammad, Hafez, Mohamed Hany, Hassan, Mohamed H, Sqalli, Tarik
Format:	Article
Language:	eng
Subjects:	Aldosterone Algorithms Angiotensin chronic kidney disease Chronic kidney failure Dextrose Expert Opinion Glucose Health care industry Hypertension Hypoglycemic agents Medical screening nephrology referral Pharmaceutical industry screening sodium-glucose cotransporter - 2 inhibitors Type 2 diabetes
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Chronic kidney disease (CKD) is a major public health concern in the Middle East and Africa (MEA) region and a leading cause of death in patients with type 2 diabetes mellitus (T2DM) and hypertension. Early initiation of sodium-glucose cotransporter - 2 inhibitors (SGLT-2i) and proper sequencing with renin-angiotensin-aldosterone system inhibitors (RAASi) in these patients may result in better clinical outcomes due to their cardioprotective properties and complementary mechanisms of action. In this review, we present guideline-based consensus recommendations by experts from the MEA region, as practical algorithms for screening, early detection, nephrology referral, and treatment pathways for CKD management in patients with hypertension and diabetes mellitus. This study will help physicians take timely and appropriate actions to provide better care to patients with CKD or those at high risk of CKD.
ISSN:	1178-7058 1178-7058